Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Genet Med (2008) 10:412.10.1097/GIM.0b013e31815efdd7 11 NealeBMKouYLiuLMaayanASamochaKESaboAet alPatterns and rates of exonic de novo mutations in autism spectrum disorders
Food and Drug Administration (FDA) has approved semaglutide, a glucagon-like peptide receptor agonist (GLP-1RA), to treat type 2 diabetes mellitus (T2DM) and obesity
Ein fall von tumor der hypophysis cerebri ohne akromegalie
Thus, key metabolic and neurobehavioral dysregulations of BBS were effectively recapitulated in Bbs5 / mice, which offer a robust platform for dissecting BBS pathophysiology and developing potential therapeutic strategies
US$ 26.08
.png)
US$ 23.25
US$ 23.67
US$ 28.61
US$ 21.13
US$ 28.88
